Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Enzyme Replacement Therapy in Fabry Disease

This study has been terminated.
(Difficulties in the patient's enrolment)
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research Identifier:
First received: September 6, 2005
Last updated: November 7, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2014
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)